Individual differences in acute pain-induced endogenous analgesia predict time to resolution of postoperative pain in the rat

Anesthesiology

Volumn 122, Issue 4, 2015, Pages 895-907

  Peters, Christopher M ^a   Hayashida, Ken Ichiro ^a   Suto, Takashi ^a   Houle, Timothy T ^a   Aschenbrenner, Carol A ^a   Martin, Thomas J ^a   Eisenach, James C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; CAPSAICIN; IDAZOXAN; SAPORIN;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HYPERSENSITIVITY; MALE; NERVE LIGATION; NONHUMAN; NORADRENERGIC SYSTEM; PERIPHERAL NERVE INJURY; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RAT; WEIGHT BEARING; ACUTE PAIN; ANIMAL; PAIN, POSTOPERATIVE; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PYRAMIDAL TRACT; SPRAGUE DAWLEY RAT; TIME FACTOR;

ACUTE PAIN; ANALGESIA; ANIMALS; MALE; PAIN, POSTOPERATIVE; PREDICTIVE VALUE OF TESTS; PYRAMIDAL TRACTS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 84937251757     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000593     Document Type: Article

References (66)

1. Kehlet H, Jensen TS, Woolf CJ: Persistent postsurgical pain: Risk factors and prevention. Lancet 2006; 367:1618-25
2. Althaus A, Hinrichs-Rocker A, Chapman R, Arránz Becker O, Lefering R, Simanski C, Weber F, Moser KH, Joppich R, Trojan S, Gutzeit N, Neugebauer E: Development of a risk index for the prediction of chronic post-surgical pain. Eur J Pain 2012; 16:901-10
3. McGreevy K, Bottros MM, Raja SN: Preventing chronic pain following acute pain: Risk factors, preventive strategies, and their efficacy. Eur J Pain Suppl 2011; 5:365-72
4. Diatchenko L, Nackley AG, Tchivileva IE, Shabalina SA, Maixner W: Genetic architecture of human pain perception. Trends Genet 2007; 23:605-13
5. Yarnitsky D, Crispel Y, Eisenberg E, Granovsky Y, Ben-Nun A, Sprecher E, Best LA, Granot M: Prediction of chronic postoperative pain: Pre-operative DNIC testing identifies patients at risk. Pain 2008; 138:22-8
6. Wilder-Smith OH, Schreyer T, Scheffer GJ, Arendt-Nielsen L: Patients with chronic pain after abdominal surgery show less preoperative endogenous pain inhibition and more postoperative hyperalgesia: A pilot study. J Pain Palliat Care Pharmacother 2010; 24:119-28
7. Tyce GM, Yaksh TL: Monoamine release from cat spinal cord by somatic stimuli: An intrinsic modulatory system. J Physiol 1981; 314:513-29
8. Pertovaara A: Noradrenergic pain modulation. Prog Neurobiol 2006; 80:53-83
9. Hughes SW, Hickey L, Hulse RP, Lumb BM, Pickering AE: Endogenous analgesic action of the pontospinal noradrenergic system spatially restricts and temporally delays the progression of neuropathic pain following tibial nerve injury. Pain 2013; 154:1680-90
10. Jasmin L, Boudah A, Ohara PT: Long-term effects of decreased noradrenergic central nervous system innervation on pain behavior and opioid antinociception. J Comp Neurol 2003; 460:38-55
11. Brightwell JJ, Taylor BK: Noradrenergic neurons in the locus coeruleus contribute to neuropathic pain. Neuroscience 2009; 160:174-85
12. McEwen BS, Wingfield JC: The concept of allostasis in biology and biomedicine. Horm Behav 2003; 43:2-15
13. Sterling P, Eyer J: Allostasis: A new paradigm to explain arousal pathology, Handbook of Life Stress, Cognition and Health. Edited by Fisher S, Reason J. New York, John Wiley & Sons, 1988, pp 629-64
14. Aley KO, Messing RO, Mochly-Rosen D, Levine JD: Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the epsilon isozyme of protein kinase C. J Neurosci 2000; 20:4680-5
15. Asiedu MN, Tillu DV, Melemedjian OK, Shy A, Sanoja R, Bodell B, Ghosh S, Porreca F, Price TJ: Spinal protein kinase M underlies the maintenance mechanism of persistent nociceptive sensitization. J Neurosci 2011; 31:6646-53
16. Wang H, Heijnen CJ, van Velthoven CT, Willemen HL, Ishikawa Y, Zhang X, Sood AK, Vroon A, Eijkelkamp N, Kavelaars A: Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain. J Clin Invest 2013; 123:5023-34
17. Corder G, Doolen S, Donahue RR, Winter MK, Jutras BL, He Y, Hu X, Wieskopf JS, Mogil JS, Storm DR, Wang ZJ, McCarson KE, Taylor BK: Constitutive opioid receptor activity leads to long-term endogenous analgesia and dependence. Science 2013; 341:1394-9
18. Solway B, Bose SC, Corder G, Donahue RR, Taylor BK: Tonic inhibition of chronic pain by neuropeptide Y. Proc Natl Acad Sci USA 2011; 108:7224-9
19. Gear RW, Aley KO, Levine JD: Pain-induced analgesia mediated by mesolimbic reward circuits. J Neurosci 1999; 19:7175-81
20. Ferrari LF, Gear RW, Levine JD: Attenuation of activity in an endogenous analgesia circuit by ongoing pain in the rat. J Neurosci 2010; 30:13699-706
21. Guan Y, Yuan F, Carteret AF, Raja SN: A partial L5 spinal nerve ligation induces a limited prolongation of mechanical allodynia in rats: An efficient model for studying mechanisms of neuropathic pain. Neurosci Lett 2010; 471:43-7
22. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994; 53:55-63
23. Wrenn CC, Picklo MJ, Lappi DA, Robertson D, Wiley RG: Central noradrenergic lesioning using anti-DBH-saporin: Anatomical findings. Brain Res 1996; 740:175-84
24. Wiley RG, Kline IV RH: Neuronal lesioning with axonally transported toxins. J Neurosci Methods 2000; 103:73-82
25. Barthelemy I, Martineau D, Ong M, Matsunami R, Ling N, Benatti L, Cavallaro U, Soria M, Lappi DA: The expression of saporin, a ribosome-inactivating protein from the plant Saponaria officinalis, in Escherichia coli. J Biol Chem 1993; 268:6541-8
26. Martin WJ, Gupta NK, Loo CM, Rohde DS, Basbaum AI: Differential effects of neurotoxic destruction of descending noradrenergic pathways on acute and persistent nociceptive processing. Pain 1999; 80:57-65
27. Hayashida K, Peters CM, Gutierrez S, Eisenach JC: Depletion of endogenous noradrenaline does not prevent spinal cord plasticity following peripheral nerve injury. J Pain 2012; 13:49-57
28. Hayashida K, Clayton BA, Johnson JE, Eisenach JC: Brain derived nerve growth factor induces spinal noradrenergic fiber sprouting and enhances clonidine analgesia following nerve injury in rats. Pain 2008; 136:348-55
29. Aschenbrenner CA, Houle TT, Gutierrez S, Eisenach JC: Modeling individual recovery after peripheral nerve injury in rats and the effects of parturition. Anesthesiology 2014; 121:1056-67
30. Wen YR, Wang CC, Yeh GC, Hsu SF, Huang YJ, Li YL, Sun WZ: DNIC-mediated analgesia produced by a supramaximal electrical or a high-dose formalin conditioning stimulus: Roles of opioid and 2-adrenergic receptors. J Biomed Sci 2010; 17:19
31. Schmidt BL, Tambeli CH, Levine JD, Gear RW: Adaptations in nucleus accumbens circuitry during opioid withdrawal associated with persistence of noxious stimulus-induced antinociception in the rat. J Pain 2003; 4:141-7
32. Eisenach JC, Detweiler DJ, Tong C, D'Angelo R, Hood DD: Cerebrospinal fluid norepinephrine and acetylcholine concentrations during acute pain. Anesth Analg 1996; 82:621-6
33. Le Bars D, Bourgoin S, Clot AM, Hamon M, Cesselin F: Noxious mechanical stimuli increase the release of Metenkephalin-like material heterosegmentally in the rat spinal cord. Brain Res 1987; 402:188-92
34. Le Bars D, Chitour D, Kraus E, Dickenson AH, Besson JM: Effect of naloxone upon diffuse noxious inhibitory controls (DNIC) in the rat. Brain Res 1981; 204:387-402
35. Tambeli CH, Quang P, Levine JD, Gear RW: Contribution of spinal inhibitory receptors in heterosegmental antinociception induced by noxious stimulation. Eur J Neurosci 2003; 18:2999-3006
36. Lanza M, Ferrari F, Menghetti I, Tremolada D, Caselli G: Modulation of imidazoline I2 binding sites by CR4056 relieves postoperative hyperalgesia in male and female rats. Br J Pharmacol 2014; 171:3693-701
37. Li JX, Thorn DA, Qiu Y, Peng BW, Zhang Y: Antihyperalgesic effects of imidazoline I(2) receptor ligands in rat models of inflammatory and neuropathic pain. Br J Pharmacol 2014; 171:1580-90
38. Howorth PW, Thornton SR, O'Brien V, Smith WD, Nikiforova N, Teschemacher AG, Pickering AE: Retrograde viral vectormediated inhibition of pontospinal noradrenergic neurons causes hyperalgesia in rats. J Neurosci 2009; 29:12855-64
39. Li X, Conklin D, Ma W, Zhu X, Eisenach JC: Spinal noradrenergic activation mediates allodynia reduction from an allosteric adenosine modulator in a rat model of neuropathic pain. Pain 2002; 97:117-25
40. Loughlin SE, Foote SL, Bloom FE: Efferent projections of nucleus locus coeruleus: Topographic organization of cells of origin demonstrated by three-dimensional reconstruction. Neuroscience 1986; 18:291-306
41. Bruinstroop E, Cano G, Vanderhorst VG, Cavalcante JC, Wirth J, Sena-Esteves M, Saper CB: Spinal projections of the A5, A6 (locus coeruleus), and A7 noradrenergic cell groups in rats. J Comp Neurol 2012; 520:1985-2001
42. Hickey L, Li Y, Fyson SJ, Watson TC, Perrins R, Hewinson J, Teschemacher AG, Furue H, Lumb BM, Pickering AE: Optoactivation of locus ceruleus neurons evokes bidirectional changes in thermal nociception in rats. J Neurosci 2014; 34:4148-60
43. Ewan EE, Martin TJ: Differential suppression of intracranial self-stimulation, food-maintained operant responding, and open field activity by paw incision and spinal nerve ligation in rats. Anesth Analg 2014; 118:854-62
44. Ji RR, Berta T, Nedergaard M: Glia and pain: Is chronic pain a gliopathy. Pain 2013; 154(suppl 1):S10-28
45. McMahon SB, Cafferty WB, Marchand F: Immune and glial cell factors as pain mediators and modulators. Exp Neurol 2005; 192:444-62
46. Li SS, Zhang WS, Ji D, Zhou YL, Li H, Yang JL, Xiong YC, Zhang YQ, Xu H: Involvement of spinal microglia and interleukin-18 in the anti-nociceptive effect of dexmedetomidine in rats subjected to CCI. Neurosci Lett 2014; 560:21-5
47. Xu B, Zhang WS, Yang JL, Lû N, Deng XM, Xu H, Zhang YQ: Evidence for suppression of spinal glial activation by dexmedetomidine in a rat model of monoarthritis. Clin Exp Pharmacol Physiol 2010; 37:e158-66
48. Morioka N, Tanabe H, Inoue A, Dohi T, Nakata Y: Noradrenaline reduces the ATP-stimulated phosphorylation of p38 MAP kinase via adrenergic receptors-cAMP-protein kinase A-dependent mechanism in cultured rat spinal microglia. Neurochem Int 2009; 55:226-34
49. Morioka N, Abe H, Araki R, Matsumoto N, Zhang FF, Nakamura Y, Hisaoka-Nakashima K, Nakata Y: A 1/2 adrenergic receptor-sensitive intracellular signaling pathway modulates CCL2 production in cultured spinal astrocytes. J Cell Physiol 2014; 229:323-32
50. Bourgoin S, Pohl M, Mauborgne A, Benoliel JJ, Collin E, Hamon M, Cesselin F: Monoaminergic control of the release of calcitonin gene-related peptide-and substance P-like materials from rat spinal cord slices. Neuropharmacology 1993; 32:633-40
51. Mori K, Ozaki E, Zhang B, Yang L, Yokoyama A, Takeda I, Maeda N, Sakanaka M, Tanaka J: Effects of norepinephrine on rat cultured microglial cells that express 1, 2, 1 and 2 adrenergic receptors. Neuropharmacology 2002; 43:1026-34
52. Célèrier E, Rivat C, Jun Y, Laulin JP, Larcher A, Reynier P, Simonnet G: Long-lasting hyperalgesia induced by fentanyl in rats: Preventive effect of ketamine. Anesthesiology 2000; 92:465-72
53. De Felice M, Sanoja R, Wang R, Vera-Portocarrero L, Oyarzo J, King T, Ossipov MH, Vanderah TW, Lai J, Dussor GO, Fields HL, Price TJ, Porreca F: Engagement of descending inhibition from the rostral ventromedial medulla protects against chronic neuropathic pain. Pain 2011; 152:2701-9
54. Xu M, Kontinen VK, Kalso E: Endogenous noradrenergic tone controls symptoms of allodynia in the spinal nerve ligation model of neuropathic pain. Eur J Pharmacol 1999; 366:41-5
55. Ma W, Eisenach JC: Chronic constriction injury of sciatic nerve induces the up-regulation of descending inhibitory noradrenergic innervation to the lumbar dorsal horn of mice. Brain Res 2003; 970:110-8
56. Nakajima K, Obata H, Iriuchijima N, Saito S: An increase in spinal cord noradrenaline is a major contributor to the antihyperalgesic effect of antidepressants after peripheral nerve injury in the rat. Pain 2012; 153:990-7
57. Mogil JS: Animal models of pain: Progress and challenges. Nat Rev Neurosci 2009; 10:283-94
58. Mogil JS: The genetic mediation of individual differences in sensitivity to pain and its inhibition. Proc Natl Acad Sci USA 1999; 96:7744-51
59. Marek P, Panocka I, Sadowski B: Selective breeding of mice for high and low swim analgesia: Differential effect on discrete forms of footshock analgesia. Pain 1987; 29:393-8
60. Marek P, Yirmiya R, Liebeskind JC: Strain differences in the magnitude of swimming-induced analgesia in mice correlate with brain opiate receptor concentration. Brain Res 1988; 447:188-90
61. Johansen A, Romundstad L, Nielsen CS, Schirmer H, Stubhaug A: Persistent postsurgical pain in a general population: Prevalence and predictors in the Tromsø study. Pain 2012; 153:1390-6
62. Kaasa T, Romundstad L, Roald H, Skolleborg K, Stubhaug A: Hyperesthesia one year after breast augmentation surgery increases the odds for persisting pain at four years. Scand J Pain 2010; 1:75-81
63. Chapman CR, Davis J, Donaldson GW, Naylor J, Winchester D: Postoperative pain trajectories in chronic pain patients undergoing surgery: The effects of chronic opioid pharmacotherapy on acute pain. J Pain 2011; 12:1240-6
64. Chapman CR, Donaldson GW, Davis JJ, Bradshaw DH: Improving individual measurement of postoperative pain: The pain trajectory. J Pain 2011; 12:257-62
65. Yarnitsky D, Granot M, Nahman-Averbuch H, Khamaisi M, Granovsky Y: Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy. Pain 2012; 153:1193-8
66. Niesters M, Proto PL, Aarts L, Sarton EY, Drewes AM, Dahan A: Tapentadol potentiates descending pain inhibition in chronic pain patients with diabetic polyneuropathy. Br J Anaesth 2014; 113:148-56